Congress and federal agencies should recognize that the drug landscape has shifted.

The Drug Enforcement Administration’s scheduling process, the FDA’s regulatory framework, and federal early‑warning systems must adapt to a world in which criminal chemists can pull potent molecules directly from the scientific literature, writes guest columnist Jon E. Sprague, director of science & research for the Ohio Attorney General’s Office and BCI Eminent Scholar at Bowling Green State University.

NewsBeagle is a discovery engine. We show the headline, a short source-supplied summary and clear attribution. The complete reporting remains with the publisher.